Funding for this research was provided by:
Research unit of South Egypt cancer institute
Received: 15 November 2021
Accepted: 4 January 2022
First Online: 10 January 2022
: The study was conducted after approval of the Ethical Committee of South Egypt Cancer Institute (Approval Number 439). Informed written consent was obtained from each participant.
: All patients included in this study gave a written informed consent to publish the data contained in this study.
: The authors declare that they have no competing interests.